表紙:精神疾患治療市場 - 疾患タイプ・治療薬・流通チャネル・地域別:市場規模・シェア・展望・機会・分析 (2020-2027年)
市場調査レポート
商品コード
980010

精神疾患治療市場 - 疾患タイプ・治療薬・流通チャネル・地域別:市場規模・シェア・展望・機会・分析 (2020-2027年)

Mental Disorder Treatment Market, by Disorder Type, by Medication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 175 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.03円
精神疾患治療市場 - 疾患タイプ・治療薬・流通チャネル・地域別:市場規模・シェア・展望・機会・分析 (2020-2027年)
出版日: 2020年12月23日
発行: Coherent Market Insights
ページ情報: 英文 175 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

精神障害には、うつ病、双極性障害、統合失調症、認知症、心的外傷後障害 (PTSD) など、さまざまな種類の精神障害が含まれます。これらの精神障害は、薬物療法または精神療法の助けを借りて治療されます。さらに、これらの精神障害の治療に使用されるさまざまな薬には、抗うつ薬、抗不安薬、抗精神病薬、精神安定剤などがあります。

主要企業は、世界の精神疾患治療市場における地位を強化するために、うつ病、双極性障害などの精神疾患の治療薬の発売に焦点を合わせています。たとえば、2017年、Lupin Limitedは、主要なうつ病性障害の治療に適応となる抗うつ薬の塩酸ブプロピオン徐放錠を米国市場で発売しました。

当レポートでは、世界の精神疾患治療市場について調査し、市場の概要、市場動向、市場に影響を及ぼす要因の分析、需要分析、各セグメント・地域別の市場分析、価格分析、主要企業のプロファイルなどを提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

  • レポートの説明
  • 市場の定義と範囲
  • エグゼクティブサマリー
  • 市場内訳:疾患タイプ別
  • 市場内訳:治療薬
  • 市場内訳:流通チャネル別
  • 市場内訳:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 影響分析
  • 主な発展
  • 新製品の発売/承認
  • 合併買収シナリオ
  • 規制シナリオ
  • パイプライン分析
  • 疫学
  • PEST分析
  • 医療費償還

第4章 世界の精神疾患治療市場:コロナウイルス(Covid-19)パンデミックの影響

  • COVID-19:メンタルヘルスへの影響
  • COVID-19:需要と供給への影響

第5章 世界の精神疾患治療市場:疾患タイプ別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメント動向
    • うつ病
    • 両極性障害
    • 統合失調症
    • 認知症
    • PTSD (心的外傷後障害)
    • その他

第6章 世界の精神疾患治療市場:薬剤タイプ別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメント動向
    • 抗うつ薬
    • 抗不安薬
    • 精神安定剤
    • 抗精神病薬

第7章 世界の精神疾患治療市場:流通チャネル別

  • イントロダクション
  • 市場シェア分析
  • 前年比成長分析
  • セグメント動向
    • 病院薬局
    • 小売り薬局
    • オンライン薬局

第8章 世界の精神疾患治療市場:地域別

  • イントロダクション
  • 市場シェア分析:国別
  • 前年比成長分析:国別
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第9章 競合情勢

  • 企業プロファイル
    • Allergan plc
    • Eli Lilly and Company
    • VistaGen Therapeutics
    • Sanofi SA
    • Novartis International AG
    • Mylan NV
    • Amneal Pharmaceuticals LLC
    • Cipla Ltd
    • Sun Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Limited
    • Lupin Limited
    • Janssen Pharmaceutica
    • Bristol Myers Squibb
    • Sumitomo Dainippon Pharma Co., Ltd
目次

Title:
Mental Disorder Treatment Market, by Disorder Type (Depression, Bipolar Disorder, Schizophrenia, Dementia, Post-traumatic Stress Disorder, and Others), by Medication (Anti-depressants, Anti-anxiety, Mood Stabilizing Medication, and Antipsychotic Medications), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

The mental disorder include various different types of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, post traumatic disorders, and others. These mental disorders are treated with the help of medications or psycho-therapies. Moreover, various medications used for the treatment of these mental disorders include anti-depressants, anti-anxiety medications, anti-psychotic medications, and mood stabilizing medication.

Market Dynamics

Key companies are focusing on product launches for the treatment of mental disorders such as depression, bipolar disorders to strengthen their position in the global mental disorder treatment market. For instance, in 2017, Lupin Limited, launched its anti-depressant, Bupropion Hydrochloride extended release tablets, indicated for the treatment of major depressive disorder, in the U.S. market.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global mental disorder treatment market. The market for is segmented on basis of disorder type, medication, distribution channel, and region.
  • This report provides in-depth analysis of the global mental disorder treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global mental disorder treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global mental disorder treatment market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global mental disorder treatment market

Detailed Segmentation:

  • Global Mental Disorder Treatment Market, By Disorder Type:
    • Depression
    • Bipolar Disorder
    • Schizophrenia
    • Dementia
    • Post-traumatic Stress Disorder
    • Others
  • Global Mental Disorder Treatment Market, By Medication:
    • Anti-depressants
    • Anti-anxiety
    • Mood Stabilizing Medication
    • Antipsychotic Medications
  • Global Mental Disorder Treatment Market, By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Mental Disorder Treatment Market, By Region:
    • North America
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Disorder Type:
      • Depression
      • Bipolar Disorder
      • Schizophrenia
      • Dementia
      • Post-traumatic Stress Disorder
      • Others
      • By Medication:
      • Anti-depressants
      • Anti-anxiety
      • Mood Stabilizing Medication
      • Antipsychotic Medications
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Allergan plc.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Eli Lilly and Company
    • VistaGen Therapeutics
    • Sanofi S.A
    • Novartis International AG
    • Mylan N.V.
    • Amneal Pharmaceuticals LLC
    • Cipla Ltd
    • Sun Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Limited
    • Lupin Limited
    • Janssen Pharmaceutica
    • Bristol Myers Squibb
    • Sumitomo Dainippon Pharma Co., Ltd

"*" marked represents similar segmentation in other categories in the respective section

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Disorder Type
  • Market Snapshot, By Medication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Key Developments
  • New Product Launches/Approvals
  • Merger-Acquisition Scenario
  • Regulatory Scenario
  • Pipeline Analysis
  • Epidemiology
  • PEST Analysis
  • Reimbursement

4. Global Mental Disorder Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID 19 Impact on Mental Health
  • COVID 19 Impact on Supply and Demand

5. Global Mental Disorder Treatment Market, By Disorder Type, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Bipolar Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Schizophrenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Dementia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Post-traumatic Stress Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

6. Global Mental Disorder Treatment Market, By Medication, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Anti-depressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Anti-anxiety
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Mood Stabilizing Medication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Antipsychotic Medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

7. Global Mental Disorder Treatment Market, By Distribution Channel, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

8. Global Mental Disorder Treatment Market, By Region, 2016-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Disorder Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Medication, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Allergan plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • VistaGen Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan N.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amneal Pharmaceuticals LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cipla Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lupin Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Janssen Pharmaceutica
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sumitomo Dainippon Pharma Co., Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies